Live Breaking News & Updates on Clinical immunology

Stay informed with the latest breaking news from Clinical immunology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Clinical immunology and stay connected to the pulse of your community

Exploring the link between air pollutants and allergic diseases

Exploring the link between air pollutants and allergic diseases
airqualitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from airqualitynews.com Daily Mail and Mail on Sunday newspapers.

Michael-nevid , Donald-leung , Jessica-hui , National-jewish-health , Pediatric-allergy , Clinical-immunology ,

Pollen counts to drop

The concentration of pollen in the air is expected to reduce next week with low or moderate levels in all regions of mainland Portugal and the Islands.

Portugal , Portuguese-society-of-allergology , Portuguese-society , Clinical-immunology , Pollen-bulletin ,

Texas Tech Physicians allergist sheds light on adult-onset allergies

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

United-states , Texas , James-tarbox , Texas-tech-physicians , Clinical-immunology ,

Study Finds Relationship Between Uncontrolled Severe Asthma, Exacerbations and Health Care Resource Use

The findings emphasize a need for guideline-based care delivery for patients with severe asthma, particularly for patients who are facing social disparities within health care.

Hawaii , United-states , Alaska , Hawaiian , American , Clinical-immunology , Medicare-advantage , Hispanic-white , Native-hawaiian , Pacific-islander , American-indian

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards

Recognition given for achievement in commercializing Joenja® , a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands,...

London , City-of , United-kingdom , Australia , Amsterdam , Noord-holland , Netherlands , Japan , Canada , United-states , Americans , America

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Australia , Liechtenstein , Germany , Melbourne , Victoria , Norway , Iceland , New-zealand , Switzerland , Eric-dube , Thomas-hutter , Emmanuelle-lecomte-brisset

Pharming To Be Honored As Industry Innovator At National Organization For Rare Disorders (NORD®) 2024 Rare Impact Awards

Pharming To Be Honored As Industry Innovator At National Organization For Rare Disorders (NORD®) 2024 Rare Impact Awards
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Amsterdam , Noord-holland , Netherlands , United-states , Canada , Australia , London , City-of , United-kingdom , Japan , Americans , America

Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K

Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

...

Canada , Australia , Japan , Amsterdam , Noord-holland , Netherlands , United-states , United-kingdom , Washington , London , City-of , America

Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

First non-immunosuppressive therapy for the treatment of IgA nephropathy approved in Europe Conditional marketing authorization is based on statistically significant and clinically meaningful...

Japan , New-zealand , Australia , Norway , Iceland , Germany , Switzerland , Melbourne , Victoria , Liechtenstein , Emmanuelle-lecomte-brisset , Thomas-hutter

Travere Therapeutics (TVTX) and CSL Vifor Announce EU Approval of FILSPARI

Travere Therapeutics (TVTX) and CSL Vifor Announce EU Approval of FILSPARI
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany , Liechtenstein , Norway , Australia , New-zealand , Iceland , Emmanuelle-lecomte-brisset , Eric-dube , Committee-for-medicinal-products-human-use , European-union , Travere-therapeutics-inc , European-commission